Banyan's 'Forever Home' Strategy Enters Germany’s Regulated eHealth Market

MUNICH, GERMANY – July 10, 2026

In a strategic move that underscores a unique approach to corporate ownership, Canadian software acquirer Banyan Software has acquired HMM Germany, a pivotal player in the German eHealth landscape. The deal brings HMM, which operates a critical digital platform for managing medical aids, under the umbrella of a firm known for its "buy-grow-and-hold-for-life" philosophy—a stark contrast to the typical buy-and-flip cycle of traditional private equity. This acquisition is more than a simple transaction; it represents a long-term bet on the future of Germany's rapidly digitizing, and highly regulated, healthcare sector.

HMM, founded in 2006 and headquartered in Moers, is the engine behind X3.Net, a B2B platform that forms the digital backbone for a complex ecosystem. With over 200 employees, the company facilitates the approval, billing, and reimbursement of medical aids, connecting thousands of health insurers, medical device manufacturers, and healthcare providers in real time. For two decades, HMM has built its reputation on trust and reliability. Now, with Banyan's backing, it aims to accelerate its next phase of growth, with a significant focus on integrating artificial intelligence into its operations.

A Different Breed of Acquirer

Banyan Software is not a typical consolidator. With a portfolio of over 100 specialized software businesses worldwide, the Toronto-based firm operates on a permanent capital base, allowing it to acquire companies with no intention of selling them. This "forever home" model is designed to honor founder legacies, maintain operational stability, and foster long-term, sustainable growth.

This strategy has proven effective in complex and regulated industries across Europe. Banyan’s recent acquisitions include Gini, an AI-based financial data specialist deeply embedded in Germany’s banking sector, and Presight Solutions, a Norwegian provider of compliance software for high-risk industries. In each case, Banyan’s approach has been to preserve the acquired company's identity, leadership, and local presence while providing capital and shared expertise, particularly in artificial intelligence.

The acquisition of HMM follows this established playbook. Banyan's Operating Partner, Kay-Ingo Greve, emphasized this commitment to stability: "HMM's team has been earning the trust of the insurers and providers they serve since 2006—that's not something we take lightly. The team stays in Moers, the relationships stay intact, and we're backing that stability with real investment." This promise of continuity was a decisive factor for HMM's leadership, who were explicitly seeking a partner for the long haul.

A Strategic Entry into Germany's Digital Health Revolution

Banyan's timing is impeccable. The German eHealth market is at an inflection point, propelled by significant government investment and sweeping legislative changes. The Digital Act (DigiG) and the Health Data Use Act (GDNG), both passed recently, are aggressively pushing the healthcare system towards a digital-first future. A key mandate is the nationwide rollout of the electronic patient record (ePA) for all publicly insured individuals by 2025, with a target of 80% adoption by 2026.

This state-sponsored digital transformation is creating immense opportunities for platforms like HMM's X3.Net, which provides the essential administrative infrastructure to make such a system function efficiently. As Germany digitizes patient records and health data exchange, the need for robust, secure, and automated platforms to manage the financial and logistical components of care—such as medical aid reimbursement—becomes even more critical. Banyan is not just buying a software company; it is acquiring a foundational piece of Germany's evolving digital health ecosystem. The market, projected to surpass $90 billion by 2034, demands precisely the kind of specialized, reliable technology that HMM provides.

The Founder's Search for a Long-Term Partner

For many successful founders, the decision to sell their company is fraught with concern over the fate of their legacy, their employees, and the customer relationships they've spent years building. HMM's founder, Istok Kespret, voiced this common dilemma, making it clear that the choice of an acquirer was about more than just the financial terms. "We are proud of the platform we have built and the trust our customers have placed in us over the years," Kespret stated. "We wanted an owner who would commit to the platform for the long term, invest in it, and stand behind the customer relationships we have spent two decades building. We found that in Banyan."

This sentiment highlights a growing trend among founders of specialized, mission-driven businesses who are wary of the short-term, profit-driven motives of traditional private equity. Banyan's model offers an alternative path—an exit that ensures continuity rather than disruption. By committing to keep the team in Moers and investing in the existing platform, Banyan provides the capital for growth without demanding a sacrifice of the company's culture or core mission.

Fueling the Future with 'Responsible AI'

A central pillar of the acquisition is the plan to "accelerate AI adoption" within HMM's operations. This is not mere corporate jargon. Banyan has made AI a strategic priority across its entire portfolio, appointing a dedicated Head of AI earlier this year to deploy shared capabilities and drive innovation. For HMM, this means leveraging Banyan's expertise to enhance the X3.Net platform with what Banyan calls "responsible automation."

In the context of healthcare administration, AI can be transformative. It can streamline the verification of cost estimates, automate billing processes, and flag potential errors in real time, reducing administrative burdens for providers and speeding up reimbursements from insurers. This increased efficiency ultimately benefits patients, who experience faster access to necessary medical aids. The emphasis on "responsible" AI is crucial in a sector governed by strict data privacy laws like GDPR and national regulations. The goal is to build systems that are not only efficient but also transparent, fair, and secure. Banyan's investment will enable HMM to navigate the complexities of AI implementation in healthcare, ensuring its platform remains at the forefront of innovation while maintaining the trust it has earned over two decades.